Case Report: Ivarmacitinib in the treatment of refractory primary cutaneous amyloidosis
Abstract
Primary cutaneous amyloidosis (PCA) is a chronic, severely pruritic dermatosis characterized by amyloid deposition in the dermis. There is currently no standardized treatment for PCA, and its clinical management remains challenging. Ivarmacitinib, a novel, highly selective oral Janus kinase 1 (JAK1) inhibitor, has demonstrated significant efficacy in modulating inflammatory and pruritic pathways in atopic dermatitis (AD), suggesting its potential utility in related conditions. We report a compelling case of a 65-year-old male with a 15-year history of severe, refractory PCA who had failed multiple conventional treatments, including topical corticosteroids, systemic retinoids, and immunomodulators, owing to either poor tolerability or insufficient efficacy. Thus, ivarmacitinib was initiated as a targeted therapeutic intervention, and it resulted in rapid improvement: pruritus subsided within 24 h and resolved completely within one week, followed by significant flattening and fading of hyperpigmented papules over the ensuing weeks, with no adverse events observed during follow-up. This case suggests that ivarmacitinib may be a promising, effective, and well-tolerated therapeutic option for refractory PCA, likely through targeting the JAK/STAT pathway central to disease pathogenesis.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects
- Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study
- Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
- Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.